修改肝动脉输液化疗与伦瓦提尼布和卡梅利祖马布结合治疗高级HCC:两个病例报告

Yuan Tian1, Wenbiao Jin1, Honghua Sun1

  • 1Department of Oncology, The Affiliated Hospital of Yanbian University, Yanji City, Jilin Province, People's Republic of China.

概括

修改肝动脉输液化疗 (mHAIC) 与伦瓦替尼和卡梅利祖马布结合,为具有大型瘤或门静脉瘤血栓 (PVTT) 的晚期肝细胞癌 (HCC) 提供安全有效的治疗方法,改善了患者的服药性.